Background
Here, we report application of high-throughput near-full-length genome (NFLG) and partial HIV-1 proviral genome deep sequencing to characterize HIV in recently infected blood donors at four major blood centers in Brazil.
Study Design and Methods
From 2007-2011, 341 HIV+ blood donors from 4 blood centers were recruited to participate in a case control study to identify HIV risk factors and motivations to donate. Forty-seven (17 from São Paulo [SP], 8 from Minas Gerais [MG], 11 from Pernambuco [PE] and 11 from Rio de Janeiro [RJ]) were classified as recently infected based on testing by less-sensitive enzyme immunoassays. Five overlapping amplicons spanning the HIV genome were PCR amplified from peripheral blood mononuclear cells (PBMCs). The amplicons were molecularly bar-coded, pooled, and sequenced by an Illumina paired-end protocol.
Results
Of the 47 recently infected donor samples studied, 39 (82.9%) NFLGs and 6 (12.7%) partial fragments were de novo assembled into contiguous sequences and successfully subtyped. Subtype B was the only non-recombinant virus identified in this study and accounted for 62.2% (28/45) of samples. The remaining 37.8% (17/45) of samples showed various patterns of subtype discordance in different regions of HIV-1 genomes, indicating 2- 4 circulating recombinant subtypes derived from clades B, F and C. Fourteen samples (31.1%) from this study harbored drug resistance mutations, indicating higher rate of drug resistance among Brazilian blood donors.
Conclusion
Our findings revealed a high proportion of HIV-1 recombinants among recently infected blood donors in Brazil which has implications for future blood screening, diagnosis, therapy and vaccine development.